
Catching Up to America: Europe Recommends Leqembi® for Alzheimer’s
The European Medicines Agency (EMA) recommended approving Leqembi® (generic lecanemab) for Alzheimer’s. Originally skeptics, learn how the “Clarity AD” trial helped change their mind.